Martin Bürmann
Chairman at REALTECH AG
Profile
Martin Bürmann is currently the Chairman-Supervisory Board at REALTECH AG, Deputy Chairman-Supervisory Board at MAS Consult AG, Member at BIO Deutschland, and Partner at RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB.
He previously held positions as a Member-Supervisory Board at Heidelberg Pharma AG, Eichbaum-Brauereien AG, Apogenix AG, and ASSIMA Verbundgesellschaft mbH & Co. KG.
Dr. Bürmann received a doctorate degree from the University of Augsburg in 2001 and a graduate degree from Ruprecht-Karls-Universität Heidelberg in 1995.
Martin Bürmann active positions
| Companies | Position | Start |
|---|---|---|
| REALTECH AG | Chairman | 30/09/2018 |
| MAS Consult AG | Director/Board Member | - |
BIO Deutschland
 BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Corporate Officer/Principal | - |
RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB
 RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB Miscellaneous Commercial ServicesCommercial Services RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB is a law firm based in Mannheim, Germany. The German company has a unique perspective on the legal world and operates differently from traditional law firms. The private company's description emphasizes its distinctiveness and alternative approach to legal services. | Corporate Officer/Principal | - |
Former positions of Martin Bürmann
| Companies | Position | End |
|---|---|---|
ASSIMA Verbundgesellschaft mbH & Co. KG
 ASSIMA Verbundgesellschaft mbH & Co. KG Internet RetailRetail Trade ASSIMA Verbundgesellschaft mbH & Co. KG is a German company that specializes in mail order and internet retailing of textiles, clothing, footwear, and leather products. The private company is based in Neuss, Germany. The company was founded in 2002, and the CEO is Siegfried Despineux. | Director/Board Member | 31/12/2011 |
| HEIDELBERG PHARMA AG | Director/Board Member | 31/12/2010 |
Eichbaum-Brauereien AG /Keilbach/
 Eichbaum-Brauereien AG /Keilbach/ Financial ConglomeratesFinance Eichbaum-Brauereien AG /Keilbach/ is led by Jochen Keilbach. The private company is based in Mannheim, Germany. | Director/Board Member | 31/12/2009 |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Director/Board Member | - |
Training of Martin Bürmann
| University of Augsburg | Doctorate Degree |
| Ruprecht-Karls-Universität Heidelberg | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| REALTECH AG | Commercial Services |
| HEIDELBERG PHARMA AG | Health Technology |
| Private companies | 6 |
|---|---|
Eichbaum-Brauereien AG /Keilbach/
Eichbaum-Brauereien AG /Keilbach/ Financial ConglomeratesFinance Eichbaum-Brauereien AG /Keilbach/ is led by Jochen Keilbach. The private company is based in Mannheim, Germany. | Finance |
Apogenix AG
Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Health Technology |
BIO Deutschland
BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Commercial Services |
RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB
RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB Miscellaneous Commercial ServicesCommercial Services RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB is a law firm based in Mannheim, Germany. The German company has a unique perspective on the legal world and operates differently from traditional law firms. The private company's description emphasizes its distinctiveness and alternative approach to legal services. | Commercial Services |
ASSIMA Verbundgesellschaft mbH & Co. KG
ASSIMA Verbundgesellschaft mbH & Co. KG Internet RetailRetail Trade ASSIMA Verbundgesellschaft mbH & Co. KG is a German company that specializes in mail order and internet retailing of textiles, clothing, footwear, and leather products. The private company is based in Neuss, Germany. The company was founded in 2002, and the CEO is Siegfried Despineux. | Retail Trade |
| MAS Consult AG |
- Stock Market
- Insiders
- Martin Bürmann
